Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Imaging Technologies' Registration Statement Declared Effective.


Business Editors/Health/Medical Writers

NEWTOWN, Pa.--(BUSINESS WIRE)--Jan. 12, 2004

Bio-Imaging Technologies, Inc. (NASDAQ/NMS: BITI BITI Bio-Imaging Technologies, Inc. (stock symbol) ) today announced that the Securities and Exchange Commission has declared effective its registration statement on Form S-3 relating to relating to relate prepconcernant

relating to relate prepbezüglich +gen, mit Bezug auf +acc 
 the resale resale n. selling again, particularly at retail. In many states a "resale license" or "resale number" is required so that the state can monitor the collection of sales tax on retail sales.


RESALE.
 by the holders of shares of Bio-Imaging common stock. Bio-Imaging will not receive any proceeds from the sale of the shares of common stock offered by the prospectus.

This press release shall not constitute an offer to sell or the solicitation solicitation

In criminal law, the act of asking, inducing, or directing someone to commit a crime. The person soliciting another becomes an accomplice to the crime. The term also refers to the act of obtaining bribes, as well as to the crime of a prostitute who offers sexual
 of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state.

Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized spe·cial·ize  
v. spe·cial·ized, spe·cial·iz·ing, spe·cial·iz·es

v.intr.
1. To pursue a special activity, occupation, or field of study.

2.
 in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its U.S. Core Lab (Newtown, PA), European Core Lab (Leiden, The Netherlands) and U.S. Business Offices (Massachusetts and California).

Certain matters discussed in this press release are "forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
" intended to qualify for the safe harbors Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 from liability established by the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 12, 2004
Words:383
Previous Article:Fixed Wireless Infrastructure Will Ride a Wave of Growth on Standards, Reports In-Stat/MDR.
Next Article:Indus Delivers Next-Generation EAM Solution; InSite EE Combines Industry-Leading Functionality with Web-Architected Flexibility.
Topics:



Related Articles
Bio-Imaging Technologies to Release Year-End Results and Host Conference Call on February 4, 2004.
Bio-Imaging Technologies to Release First Quarter Financial Results and Host Conference Call on May 5, 2004.
Bio-Imaging Technologies to Release Second Quarter Financial Results and Host Conference Call on August 4, 2004.
Bio-Imaging Technologies to Release Third Quarter Financial Results and Host Conference Call on November 3, 2004.
Bio-Imaging Technologies to Release First Quarter Ended March 31, 2005 Financial Results and Host Conference Call on May 4, 2005.
Bio-Imaging Technologies to Release Fourth Quarter and 2005 Year End Financial Results and Host Conference Call on February 22, 2006.
Mentored Quantitative Research Development Award (K25).
Bio-Imaging Technologies to Release First Quarter 2006 Financial Results and Host Conference Call on May 3, 2006.
Bio-Imaging Technologies to Release Second Quarter 2006 Financial Results and Host Conference Call on August 2, 2006.
Bio-Imaging Technologies to Release First Quarter 2007 Financial Results and Host Conference Call on May 2, 2007.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles